Feedback / Questions
Rybrevant (amivantamab-vmjw) - Genmab, J&J
AZD9592 - AstraZeneca
"The rationale behind AZD9592, anti-EGFR/cMet bispecific ADC, via $AZN Frank Comer #AACR23 (cf $JNJ Rybrevant)"
(@JacobPlieth)
Apr 25, 2023
Oncology
https://twitter.com/JacobPlieth/status/1650882591011090435
Apr 25, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious